GTHP (Guided Therapeutics) Shiller PE Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GTHP Guided Therapeutics Inc GTHP
23 GF Score
Price $0.22
GF Value $1.08
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Guided Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Guided Therapeutics  (OTCPK:GTHP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Guided Therapeutics Shiller PE Ratio Related Terms


Guided Therapeutics Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Guided Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guided Therapeutics Shiller PE Ratio Chart

Guided Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Guided Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GTHP vs CTSO, LFWD, PETV: Shiller PE Ratio Comparison

For the Medical Devices subindustry, Guided Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guided Therapeutics Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Guided Therapeutics's Shiller PE Ratio falls into.


GTHP
23GF Score
Guided Therapeutics Inc GTHP
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guided Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Guided Therapeutics's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Guided Therapeutics's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.0063/333.9520*333.9520
=-0.006

Current CPI (Jun. 2026) = 333.9520.

Guided Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 0.000 241.428 0.000
201612 -2,504.032 241.432 -3,463.611
201703 -176.000 243.801 -241.080
201706 -472.000 244.955 -643.487
201709 -280.000 246.819 -378.847
201712 -116.424 246.524 -157.713
201803 0.408 249.554 0.546
201806 0.000 251.989 0.000
201809 -1.920 252.439 -2.540
201812 -1.032 251.233 -1.372
201903 -0.069 254.202 -0.091
201906 -0.808 256.143 -1.054
201909 -0.038 256.759 -0.049
201912 0.326 256.974 0.424
202003 0.041 258.115 0.054
202006 -0.568 257.797 -0.736
202009 0.025 260.280 0.032
202012 0.161 260.474 0.207
202103 -0.043 264.877 -0.055
202106 -0.087 271.696 -0.107
202109 -0.004 274.310 -0.005
202112 -0.037 278.802 -0.045
202203 -0.051 287.504 -0.059
202206 -0.038 296.311 -0.043
202209 -0.030 296.808 -0.034
202212 -0.039 296.797 -0.044
202303 -0.020 301.836 -0.022
202306 -0.032 305.109 -0.034
202309 -0.014 307.789 -0.015
202312 -0.009 306.746 -0.009
202403 -0.008 312.332 -0.009
202406 -0.014 314.175 -0.014
202409 -0.012 315.301 -0.013
202412 -0.011 315.605 -0.012
202503 -0.007 319.799 -0.007
202506 -0.011 322.561 -0.011
202509 -0.010 324.800 -0.010
202512 -0.014 324.054 -0.015
202603 -0.011 330.213 -0.012
202606 -0.006 333.952 -0.006

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Guided Therapeutics (GTHP) Overvalued in 2026?

Based on GuruFocus' analysis, Guided Therapeutics stock appears to be undervalued. The current stock price of $0.22 is trading 79.6% below its estimated GF Value™ of $1.08. GuruFocus considers Guided Therapeutics to be Possible Value Trap.

Key valuation signals for GTHP:

  • Shiller PE Ratio:
  • GF Value™: $1.08 vs. price of $0.22 (79.6% below fair value)
  • GF Score™: 23/100 with 3 warning signs

No single metric tells the full story. See the GTHP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc. is a medical device company based in the United States that develops non-invasive cancer detection technology. Its principal product is the LuViva Advanced Cervical Scan, a device that uses biophotonic technology to detect cervical cancer and pre-cancerous conditions without the need for tissue samples, aiming to provide immediate results at the point of care. The company also seeks to extend its detection platform to other cancers, including esophageal cancer. Guided Therapeutics targets healthcare providers, clinics, and women's health markets, primarily in the United States and select international markets. Revenue is generated through the sale of its medical devices and related disposables, though commercialization has depended on regulatory clearances and distribution partnerships. The company operates in the medical technology sector and invests in research and development to advance its biophotonic detection platform.
23GF Score

Get the complete analysis for GTHP

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$1.08
GF Value